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ABSTRACT
IMPLEMENTING THE USE OF INTRACUFF ALKALINIZED LIDOCAINE AMONG
CERTIFIED REGISTERED NURSE ANESTHETISTS: A PRACTICE CHANGE
PROPOSAL
by Shawn Taylor
December 2017
Patients today are experiencing comorbidities predisposing them to increased risk
under general anesthesia. Emergence cough reflex is a response that can lead to
hemodynamic alterations occurring during emergence and the postoperative period for
many patients requiring general endotracheal tube anesthesia (GETA). It is proposed that
38% to 96% of patients receiving GETA will experience coughing during emergence
(As, Iqbal, & Ali, 2009; Watkins, Lee, White Jr, & Mundy, 2012).
The use of intracuff alkalinized lidocaine is an intervention shown to be effective
in previous studies at blunting this response during anesthesia emergence. Through
verbal communication with CRNAs, it was discovered that the use of intracuff
alkalinized lidocaine was not currently being used at a facility in Southeastern
Mississippi. An evidence-based poster presentation and brochure was prepared using the
most recent studies utilizing intracuff alkalinized lidocaine and was presented to the
CRNAs at this facility. 18 CRNAs participated in the baseline survey, evidence-based
poster presentation, and received a brochure which illustrated the recent research findings
on the use of intracuff alkalinized lidocaine. Two weeks after the presentation, 12
CRNAs participated in the follow-up survey. The follow-up surveys demonstrated the
percentage use of intracuff alkalinized lidocaine was increased from 0% to 33% among
ii

CRNAs participating in this project. A total of four CRNAs implemented the
intervention, reported 11 total cuff inflations in which 82% effectively inhibited the
emergence cough reflex. The CRNAs reported that the main barrier to use intracuff
alkalinized lidocaine was no recent patient interaction where it would be beneficial to the
patients. Through individually presenting CRNAs with the evidence of intracuff
alkalinized lidocaine’s effectiveness, the goal of this project was to increase the
utilization of intracuff alkalinized lidocaine by CRNAs to prevent emergence cough
reflex.
.
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CHAPTER I - INTRODUCTION
Every year, millions of patients undergo general anesthesia for surgical
intervention without complications though risks are still involved (National Institute of
General Medical Sciences, 2016). General anesthesia is a procedure to prevent pain and
allow for unconsciousness during a surgical procedure (National Institute of General
Medical Sciences, 2016). For the patient population undergoing surgical intervention,
coughing generally occurs while emerging from general endotracheal tube anesthesia
(GETA) (Wetzel, Ancona, Cooper, Kortman, Loniewski, & Lebeck, 2008). An estimated
38% to 96% of patients receiving GETA will experience coughing during emergence
(As, Iqbal, & Ali, 2009; Watkins, Lee, White Jr, & Mundy, 2012). This cough response
occurs due to the presence of an endotracheal tube (ETT) irritating stretch receptors
located throughout the inner mucosa of the trachea (Wetzel, et. al., 2008). This cough
response in a normal healthy patient may pose minimal problems. The cough response in
patients with systemic disease or acute episodes of illness may cause serious
hemodynamic alterations rendering them susceptible to an increased mortality rate in the
postoperative period. A combination of smooth emergence along with awake extubation
is generally needed in many of the cases where hemodynamic alterations may need to be
avoided.
Background
Anesthesia providers are responsible for the patient’s hemodynamic state by
intervening to assure a safe, smooth awakening from general anesthesia to avoid
postoperative complications. Currently, there is no guideline endorsed by the American
Association of Nurse Anesthetists (AANA) or American Society of Anesthesiologists
1

(ASA) for preventing the emergence cough reflex. D’Aragon, Beaudet, Gagnon, Martin,
& Sansoucy (2013) suggested that many methods have been considered to decrease the
adverse effects of mucosal irritation such as opioid administration, extubating while
under deep anesthesia, and the use of intravenous (IV) lidocaine prior to
emergence. Anesthetics have demonstrated effectiveness in reducing emergence cough
but may also pose a delayed time to recovery for patients to respond to simple commands
(D’Aragon, et. al., 2013). This delayed time to recovery promotes the use of local
anesthetics as a great alternative for rapid awakening from anesthesia while maintaining
cough suppression (D’Aragon, et. al., 2013). Estebe, Treggiari, Richebe, Joffe,
Chevanne, and Le Corre (2014) suggested many nonpharmacological methods to reduce
mucosal irritation such as smaller diameter ETT, water soluble lubricant applied to cuff,
tracheal intubation after full muscle relaxation, and maintaining normal cuff
pressure. Navarro, Lima, Aguiar, Braz, Carness, & Modolo (2012) reported the delivery
of alkalinized lidocaine through the ETT cuff is a method used to decrease tracheal
mucosa irritation by inducing an anesthetic action on tracheal receptors in contact with
ETT cuff. This effect increases tolerance to ETT cuff inflation, minimizes hemodynamic
alterations, and reduces the incidence of emergence cough during tracheal extubation.
Significance
This Doctor of Nursing Practice (DNP) project was aimed at implementing a
practice change for certified registered nurse anesthetists (CRNA) to promote smooth
emergence upon awakening anesthetized patients. This DNP project was started to
evaluate whether a practice change would be implemented by CRNAs suggesting ETT
cuff inflation with alkalinized lidocaine. This practice change proposal was
2

recommended to improve patient outcomes by decreasing the occurrence of coughing
while emerging from general anesthesia. The primary goal of this DNP project was to
determine whether CRNAs were willing to change practice to decrease emergence cough
by using intracuff alkalinized lidocaine. During emergence from GETA, coughing
commonly occurs that can delay readiness for extubation, which can affect the patient
and anesthesia team in many ways. Coughing can cause long turnover times between
cases possibly leading to a reduced surgical workload by surgeons (Watkins, Lee, White
Jr, & Mundy, 2012). Long turnover times can give rise to increased organizational costs
due to administrative meetings to assess workflow of cases. Prolonged extubation time
can lead to increases in anesthesia billing units and lengthen the time needed in the
operating room (Watkins, Lee, White Jr, & Mundy, 2012). This delay in recovery time
due to emergence cough could increase the cost to both the hospital and patients.
Coughing can also continue into the post-anesthesia care unit (PACU) leading to a delay
in discharge, overall patient dissatisfaction, and may cause the surgical facility increased
labor costs (Watkins, Lee, White Jr, & Mundy, 2012). This practice change was intended
to avoid these complications by suggesting that for surgical procedures exceeding two
hours, the use of intracuff alkalinized lidocaine, as opposed to air, was effective at
preventing emergence cough (D’Aragon, et. al., 2013). The aim of this DNP project was
to suggest a practice change to CRNAs to use intracuff alkalinized 2% lidocaine to
decrease or prevent possible complications at emergence.
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Needs Assessment
A strengths, weaknesses, opportunities, and threats (SWOT) analysis was
conducted to identify the need for implementation of intracuff alkalinized lidocaine as
depicted in Table 1.
Table 1
SWOT Analysis
Strengths
•
•
Internal

•
•
•

Weaknesses

Shown effective at decreasing
emergence cough reflex.
Shown effective at decreasing
post-operative sore throat.
Easy to use.
Cost of medications
inexpensive.
Does not inhibit the
swallowing reflex.

•
•
•
•

Opportunities
•
•
External
•
•

CRNAs willing to implement
intervention may decrease
emergence cough reflex.
Can maintain hemodynamic
stability during emergence.
CRNAs can improve readiness
for extubation time.
Could improve patient
satisfaction by decreasing
cough.

•
•
•
•

•

Only effective in case
durations lasting greater
than two hours.
After six hours, it can
change integrity of ETT
cuff.
Extra step to mix lidocaine
and bicarbonate solution.
Not endorsed by AANA or
ASA.
Threats
Not used widespread
among CRNAs to decrease
emergence cough.
CRNAs not willing to
implement the intervention.
Additional step of mixing
medications for use.
May not have patient
interactions where
intervention would be
beneficial.
CRNAs may not support
the evidence shown in
current studies.

Note. SWOT= strengths, weaknesses, opportunities, and threats.

This DNP project was conducted in a 512-bed level II trauma center where
multiple general endotracheal tube anesthesia (GETA) cases are conducted daily. This
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site was chosen due to the large number of surgical cases consisting of trauma surgery,
neurosurgery, and cardiovascular surgery. Currently, the CRNAs are using IV lidocaine,
laryngotracheal administration (LTA) of lidocaine, and use of IV opiates to prevent
coughing during emergence. Intracuff alkalinized lidocaine was not being used at this
facility to decrease emergence cough. Many patients at this facility have comorbidities
such as heart disease, hypertension (HTN), obesity, diabetes mellitus (DM), and
cerebrovascular accidents (CVA) that place them at greater risk for hemodynamic
alterations from emergence cough. Hemodynamic alterations can pose many challenges
to the anesthesia provider while performing induction, maintenance, and emergence from
GETA. Using alkalinized lidocaine in the ETT cuff may allow for smooth emergence in
these patient populations to maintain hemodynamic stability in the postoperative period.
Clinical Question and Purpose
The purpose of this project was to propose a practice change to CRNAs through
an evidence-based poster presentation and brochure on the use of intracuff alkalinized
lidocaine to decrease emergence cough. The clinical question focused on whether
CRNAs were willing to change their current practice to use intracuff alkalinized lidocaine
to prevent emergence cough. This DNP project evaluated whether CRNAs implemented
the practice change to decrease emergence cough.
Overview of Synthesis of Evidence
A synthesis of evidence, focused on the use of intracuff alkalinized lidocaine at
preventing the cough response in patients requiring GETA, was conducted. The
synthesis of evidence focused on the administration of intracuff alkalinized lidocaine
compared to ETT cuff inflation with air at preventing emergence cough. This synthesis
5

of evidence sought to find the best evidence-based results to suggest a practice change to
CRNAs. Evidence demonstrated intracuff alkalinized lidocaine to be effective at
inhibiting or decreasing the emergence cough reflex in surgical case durations lasting
longer than 120 minutes.
Synthesis of Evidence
A literature search was performed to establish evidence-based information
regarding the use of ETT intracuff alkalinized lidocaine to reduce or prevent cough
response in patients upon emergence. The search was performed through The University
of Southern Mississippi’s (USM) online library accessing multiple databases. The
databases searched were PubMed, Google Scholar, and the Cochrane Library. The
search terms utilized were lidocaine, alkalinized lidocaine, intracuff, ETT, cough, and
emergence. The search terms were used in different combinations to construct advance
searches that would result in evidence-based articles. All searches were modified to full
text articles within the last eight years. Inclusion criteria consisted of articles being
written in English language and which demonstrated effectiveness of using intracuff
alkalinized lidocaine in reducing cough emergence. Exclusion criteria consisted of any
articles that were not published in the English language, which were not published within
past eight years, or irrelevant to the proposed project topic. A combined total of 144
articles resulted from advanced searches; from this, 14 articles were accepted. Of the 144
articles resulted, most articles were excluded due to intracuff alkalinized lidocaine being
used in prevention of other complications rather than inhibiting emergence cough reflex
or showed irrelevant data to the topic.

6

Endotracheal tubes
Endotracheal tubes are used during surgery to provide a definitive airway to allow
for gas exchange and administration of volatile anesthetics while preventing aspiration of
secretions, blood, or gastric contents into the lungs. ETTs are flexible catheters inserted
through the nose or mouth into the trachea to secure airway. ETTs have a cuff that can
be inflated with air or liquid to seal the trachea from gas leaks or aspiration (Mali,
Solanki, & Deshpande, 2017). Excessive cuff inflation can cause decreased tracheal
capillary perfusion, while minimal cuff inflation can possibly allow for aspiration of
secretions, blood, or gastric content (Mali, Solanki, & Deshpande, 2017).
Emergence
Emergence is defined as the return to baseline physiologic function of all organ
systems as a patient transitions from the general anesthetic sleep state to full
consciousness (Burns, 2003). Emergence consists of returning through four stages of
anesthesia as described in Table 2. As patients progress to an awakened state from
GETA, they may experience temporary neurologic dysfunction, such as mental
confusion, impaired speech, or impairments in sensory or motor function. Delayed
emergence is another phenomenon that can occur in any patient. Delayed emergence is
defined as slow awakening by patient after receiving general anesthesia usually caused by
drug effects, metabolic disorders, or neurologic disorders (Tzabazis, Miller, Dobrow,
Zheng, & Brock, 2015). This phenomenon can occur with overdosing of opioid
medications in any population, but most commonly occurs in elderly populations
(Tzabazis, Miller, Dobrow, Zheng, & Brock, 2015).
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Table 2
Four Stages of Anesthesia
Four Stages of Anesthesia
Stage I.

Induction of anesthesia to loss of consciousness. (amnestic state)

Stage II.

Excitation, delirium, tachycardia, involuntary movement, elevated blood
pressure, potential for laryngospasm, pupillary dilation (fight or flight
response)

Stage III.

Adequate anesthesia depth, regular respiration, pupillary constriction,
absence of movement (surgical anesthesia)

Stage IV. Minimal or no respiratory effort, non-reactive pupils, cardiovascular
effects, hypotension (overdose)

Emergence Cough Reflex
Emergence cough reflex commonly occurs during awakening from general
anesthesia. The proposed method of action by which this cough response is initiated is
usually related to presence of an ETT cuff applying pressure to tracheal wall (Wetzel, et.
al., 2008). Stretch receptors located throughout the inner tracheal mucosa can become
stimulated by irritants such as an ETT (Wetzel, et. al., 2008). These superficial tracheal
receptors are found just below the epithelium of the tracheal mucosa allowing for easy
stimulus by irritants. Crerar, Weldon, Salazar, Gann, Kelly, & Pellegrini (2008) reported
inherent causes of the cough reflex can be from ETT insertion, ETT cuff inflation
pressure, positive-pressure ventilation, or by volatile agents used to maintain the
anesthetic state. These possible irritating causes activate minimally myelinated
nociceptive fibers in the tracheal mucosa causing ETT induced cough reflex (Crerar, et.
al., 2008). According to Abbasi, et. al. (2013), the tracheal mucosa is an extremely
8

fragile tissue as evidenced by recent studies showing the use of a simple cotton swab
pulled across the mucosa caused loss of epithelium. Furthermore, patients with
hyperactive airways such as seen in smokers may have hypersensitive receptors located
in the trachea that predispose these patients to more frequent and forceful coughing
during extubation (Jaichandran, Bhanulakshi, Jagadeesh, & Thennarasu, 2009).
Detriments of Emergence Cough
Emergence cough can predispose patients to hemodynamic alterations such as
increased intracranial pressure (ICP), increased intraocular pressure (IOP), elevated
systolic blood pressure (SBP), tachycardia, increased abdominal pressure, and possible
disruption of sutured surgical wound closure (D’Aragon, et. al., 2013). D'Aragon, et. al.
(2013) reported bronchospasm, laryngospasm, and aspiration are also complications that
may occur. Laryngospasm can be a significant event occurring during intubation and
extubation in patients who require GETA. Laryngospasm can be caused by coughing that
can lead to considerable airway constriction after extubation which can be life threatening
(Watkins, et. al., 2012). Patients undergoing ophthalmic surgery involving open globe
repair can experience increased IOP, disruption of sutures, and suprachoroidal
hemorrhage from coughing if smooth emergence from GETA is not performed
(Jaichandran, et. al., 2009). Patients undergoing thyroidectomy can develop
hemorrhage resulting in a dangerous cervical hematoma that could possibly occlude the
airway if coughing is not controlled (Lee, Koo, Jeong, Kim, & Lee, 2011). Rao,
Snigdha, Alai, & Vijay (2013) reported the increased risk of myocardial ischemia,
tachycardia, and increased risk of bleeding during the postoperative period can be related
to cough phenomenon during emergence. During extubation and the postoperative
9

period, changes in cardiac ejection fraction and cardiac workload can predispose
susceptible patients to myocardial ischemia if tachycardia occurs (Nho, Lee, Kang, Kim,
Choi, Shin, Kim, & Kwon, 2009). Coughing during this period of recovery can cause
increases in arterial pressure, heart rate, and decrease coronary blood flow leading to
ischemia (Nho, et. al., 2009).
Lidocaine
Lidocaine, an amide local anesthetic, is a medication that can be used to inhibit
neuronal pathways. Lidocaine works by altering signal conduction in neurons
responsible for signal transduction. Lidocaine inhibits fast voltage-gated sodium
channels in the neuronal cell membrane. This action inhibits the ability of the
postsynaptic neuron to depolarize and transmit an action potential (Nagelhout & Plaus,
2014). This action causes an anesthetic effect by inhibiting pain signals before
propagation to the brain is permitted. Topical intratracheal lidocaine is currently being
used as a treatment option to prevent laryngospasm during emergence and tracheal
extubation (Watkins, et. al., 2008). Topical lidocaine s useful since tracheal receptors lie
superficially within the tracheal mucosa, allowing lidocaine to inhibit the receptor
response (Wetzel, et. al., 2008). Basuni (2014) reported intracuff alkalinized lidocaine
was suggested to continuously diffuse across the cuff membrane causing local anesthesia
to underlying trachea mucosal tissue. The semi-permeable membrane properties of the
ETT cuff and the alkalinized lidocaine solution allow for gradual diffusion of lidocaine
through the cuff membrane to reach tracheal receptors (D’Aragon, et. al., 2013). This
gradual diffusion of lidocaine slowly decreases the sensitivity of tracheal receptors
through all the critical periods of emergence. Various factors have to be considered for
10

the diffusion of intracuff alkalinized lidocaine such as alkalization, temperature, local
anesthetic concentration, and duration of the surgical procedure (Rao, et. al.,
2013). Adequate time must be allowed for alkalinized lidocaine to diffuse from the cuff
membrane to reach tracheal receptors responsible for eliciting emergence cough (Rao, et.
al., 2013).
The following sections compared the diffusion rates of intracuff alkalinized
lidocaine through polyvinyl chloride (PVC) ETTs cuffs versus polyurethane ETT cuffs.
The 50 µm thick PVC ETT cuff showed a diffusion rate different than the thinner 7 µm
polyurethane cuff. The following sections also demonstrated how intracuff alkalinized
lidocaine would diffuse the membranous cuff to elicit its localized tracheal effect. Other
uses of intracuff alkalinized lidocaine were also detailed to show the multiple benefits of
implementing the intervention.
Polyvinyl Chloride Endotracheal Tube Cuff
A controlled trial by Momota, Kakudo, Miyatani, Miyake, Tamura, Oshital, and
Kishimoto (2016) was conducted to determine diffusion rate of lidocaine solutions across
the polyvinyl chloride (PVC) membranous cuff of an oral ETT. The trial was performed
using three different lidocaine mixtures, solutions of 2 mL 4% lidocaine hydrochloride
and 4 mL distilled water (L-Gr), 2 mL 4% lidocaine hydrochloride and 4 mL 8.4%
sodium bicarbonate (LSB-Gr), or 2 mL 4% lidocaine hydrochloride and 4 mL
dipotassium phosphate (LDP-Gr). Endotracheal tube PVC cuffs were then instilled with
6 mL of each solution separately and submerged in beakers of distilled water. Samples of
0.1 mL of distilled water were removed and examined from each beaker at 30 minute
intervals for duration of six hours. Fluorescence polarization immunoassay was utilized
11

to determine the amount of lidocaine diffused through the cuff at each time
interval. Momota, et. al. 2016 reported findings of lidocaine diffusion through the cuffs
at 30 minutes of exposure in LSB-Gr and LDP-Gr. Results of L-Gr demonstrated
lidocaine concentrations ranging between 0.06 ± 0.04 µg/mL and 1.05 ± 0.34 µg/mL with
an increased concentration noted at 270 minutes. Results of lidocaine concentrations at
120 minutes were 12.0 ± 3.74 µg/mL and 133.8 ± 23.2 µg/mL for LSB-Gr, and 11.4 ±
2.41 µg/mL and 119 ± 14.8 µg/mL for LDP-Gr respectively.
The authors conducted a separate trial to examine the integrity of the PVC
membranous cuff against inadvertent rupture from diffusion of tested solutions. Intervals
of 60, 180, and 360 minutes using stereomicroscopic observation were used. The cuffs
were filled with the three solutions separately and submerged in distilled water for the
360-minute duration. The trial demonstrated no change in appearance or integrity of the
cuff at 360 minutes when L-Gr was used. The LSB-Gr and LDP-Gr filled ETT cuffs
revealed changes in appearance at sixty minutes with no cuff rupture during submersion
for 360 minutes (Momota, et. al., 2016). Furthermore, upon completion of a 360-minute
immersion, three of six cuffs instilled with LSB-Gr and two of six cuffs instilled with
LDP-Gr ruptured when manual pressure was applied. Momota, et. al. (2016) reported at
360 minutes LSB-Gr and LDP-Gr instilled cuffs became rough on surfaces exposed to
solution as compared to the control cuff of L-Gr.
The significance of this study was to show the diffusion rates of lidocaine through
a PVC ETT cuff and afterwards the integrity of the membranous cuff. It revealed the
diffusion of lidocaine to be greater after 120 minutes duration. The integrity of the cuffs
became rough on surfaces after six hours of exposure to alkalinized lidocaine but
12

remained intact, though some ETT cuffs were ruptured after six hours when direct
manual pressure was applied.
Polyurethane Endotracheal Tube Cuff.
In a different study by Estebe, et. al. (2014), the diffusion rate of alkalinized
lidocaine through the membranous ETT polyurethane cuff was measured, as well as the
safety of this procedure. In a previous study, Estebe, et. al. (2014) reported the lack of
diffusion of lidocaine when used alone was due to a low diffusion rate through the
hydrophobic membrane. They also found by adding bicarbonate to the lidocaine
solution, a relatively smaller amount of lidocaine might be used with an increased rate of
diffusion through the ETT cuff. This study evaluated the use of polyurethane high
volume, low pressure (HVLP) cuffs with a thickness of 7 µm as compared to PVC low
volume, high pressure (LVHP) cuffs with a thickness > 50 µm. Each polyurethane ETT
cuff was filled with 8 mL of varying L-B (lidocaine + bicarbonate) concentration, then
measured every 15 minutes for a 24-hour duration to evaluate amount of lidocaine
diffused through the polyurethane cuff. The release profile validated diffusion rates for
lidocaine less than 8% over 24-hour duration, while L-B showed diffusion rates greater
than 90% over a 24-hour duration. The study evaluated 24-hour durations of removing
and reinstilling the exact solution showing a similar lidocaine release profile for all eight
days of study. This study also validated another key factor in the safe use of this method
of lidocaine administration. After eight days of repeatedly instilling the L-B solution into
the same ETT cuffs there was lack of rupture of the thin polyurethane cuff in all
experiments. Furthermore, the use of lidocaine 1% in low doses and bicarbonate in low
doses decreased the risk of injury or toxicity if inadvertent cuff rupture were to
13

occur. The significance of this study was lidocaine can be used in smaller dosages when
mixed with sodium bicarbonate to diffuse through the ETT cuff. It also showed
polyurethane ETT cuffs maintained their integrity when being filled with L-B solution
and not rupturing after repeated use for eight days.
Intracuff Alkalinized Lidocaine.
A double-blind, randomized controlled trial by D’Aragon, et. al. (2013) evaluated
the use of lidocaine sprayed topically to subglottic trachea versus instilling 2%
alkalinized lidocaine into the ETT cuff. A total of 120 adult women with ASA physical
status I or II were enrolled in the study over a four-year period. These participants were
undergoing elective gynecological procedures with durations between 30 to 120
minutes. The participants were divided into 4 groups of 30 participants, in which 4%
lidocaine or 0.9% saline was sprayed topically to subglottic tracheal areas. Following
successful intubation, the ETT cuff was filled with alkalinized 2% lidocaine or 0.9%
saline. The resulting four groups: lidocaine spray - lidocaine cuff, lidocaine spray - saline
cuff, saline spray - lidocaine cuff, and saline spray - saline cuff were analyzed using
logistic regression. This study by D’Aragon, et. al. (2013) revealed that cough occurred
in 42% lidocaine spray - lidocaine cuff group, 24% lidocaine spray - saline cuff group,
63% saline spray – lidocaine cuff, and 69% saline spray – saline cuff groups. The study
detailed topical lidocaine to be more effective in preventing emergence cough in
surgeries less than 120 minutes duration (D'Aragon, et. al., 2013). The study showed 2%
alkalinized lidocaine to be ineffective in surgeries lasting less than 120 minutes duration
due to slow diffusion through the membranous ETT cuff (D'Aragon, et. al. 2013). The
significance of this study showed that the lidocaine bicarbonate solution when placed in
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an ETT cuff must be allotted a longer duration of time to diffuse through the ETT cuff
membrane to inhibit pharyngeal mucosa receptors.
A randomized, double blind clinical trial performed by Navarro, et. al. (2012) was
conducted using intracuff alkalinized 2% lidocaine as an intervention to blunt emergence
cough response in current everyday smokers. The patients were placed into two groups,
L group to receive intracuff alkalinized 2% lidocaine and S group to receive intracuff
0.9% saline. Key factors evaluated in this study include intracuff pressure, anesthesia
duration, extubation timing, and cuff solution volumes. Patients were instructed to
continue smoking prior to elective surgical date. Coughing was assessed as whether it
was present or absent in each patient during emergence. The absence of cough was
defined as no cough or coughing only during the removal of ETT, while the presence of
coughing was considered coughing during regular or irregular breathing with intact ETT.
Twenty patients experienced cough during emergence in the saline group compared to
seven patients in alkalinized 2% lidocaine group. These results were significant as it
showed intracuff alkalinized lidocaine to be nearly three times more effective at
preventing cough in smokers (p < 0.001). An additional finding showed that emergence
required less time to awakening in the lidocaine group as compared to saline group.
Use of Intracuff Lidocaine in Other Populations
Basuni (2014) evaluated the use of intracuff alkalinized lidocaine to decrease the
use of sedative infusions which predispose patients to weak inspiratory muscles or
ventilator asynchrony. A trial was conducted to evaluate the efficacy of intracuff
alkalinized lidocaine on decreasing sedative requirements and improving patientventilator synchrony in intensive care patients requiring mechanical ventilation. High
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dose sedative/analgesics are currently being used to keep patients comfortable and in
synchrony with the ventilator. High dose sedatives/analgesics can have a cumulative
effect on patients requiring more days of mechanical ventilation. Patients requiring
ventilatory support for duration of longer than 48 hours were included in the study. A
total of 64 patients were randomly assigned to intracuff saline or intracuff lidocaine
groups. The saline group had ETT cuffs instilled with 0.9% saline, while lidocaine group
had ETT cuffs instilled with alkalinized 2% lidocaine. Both groups received propofol
and fentanyl infusions for sedation during the trial. The trial recorded frequency, severity
of cough, and number of ineffective ventilator triggers during the initial 24 hours of
mechanical ventilation. Basuni (2014) reported a 30% reduction in requirements for
sedative infusions when intracuff alkalinized lidocaine was instilled in the ETT cuff (p <
0.001). He also found patients who received intracuff alkalinized lidocaine experienced
lower frequency and severity of cough (p < 0.001). Fewer episodes of elevated blood
pressure and heart rate increase were noted with use of intracuff alkalinized lidocaine
(Basuni, 2014). The study revealed that sedative/analgesic requirements were decreased
when intracuff alkalinized lidocaine was instilled. This allowed mechanical ventilation to
be more tolerable for patients in intensive care units during ventilator weaning.
A double-blind, randomized controlled trial by Abbasi et. al. (2013) was
conducted to evaluate the effectiveness of instilling 2% lidocaine into ETT cuffs in
patients requiring long-term mechanical ventilation. Damage to the tracheal mucosa
causing possible ischemia and necrosis is commonly seen in hyperinflated ETT cuffs
with pressures above 25 cm H2O (Abbasi, et. al., 2013). The trial was seeking evidence
on whether the use of intracuff 2% lidocaine was effective at decreasing tracheal mucosa
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damage from ETT cuff pressure. A total of 51 long term mechanically ventilated patients
were evaluated during this investigation. Inclusion criteria consisted of ages between 18
to 70 years, hemodynamically stable, or no recent episodes of mechanical
ventilation. Patients excluded from study had less than 48 hours of mechanical
ventilation, an ETT cuff pressure greater than 25 cm H2O, or were hemodynamically
unstable. Patients evaluated during this study were divided into intracuff lidocaine or
intracuff air groups respectively. Bronchoscopy examination of tracheal mucosa occurred
after 24 hours revealing no statistical difference between the two groups
(p=0.109). Reexamination after 48 hours of intubation revealed erythema and edema of
tracheal mucosa in 2 patients (7.7%) belonging to intracuff lidocaine group and total of 6
patients (24%) of intracuff air group experienced edema and erythema. The significance
of this study showed 2% lidocaine to be effective at reducing mucosal damage caused by
the inflated ETT cuff remaining in contact with tracheal mucosa.
Synthesis of Evidence Conclusion
The synthesis of evidence provided substantial evidence that intracuff alkalinized
lidocaine is an effective intervention in decreasing the cough response during emergence
in cases lasting a duration of greater than 120 minutes. Though intracuff alkalinized
lidocaine has been shown to be less effective as compared to topical laryngotracheal
lidocaine administration in cases less than 120 minutes duration. PVC and polyurethane
ETT cuffs were both independently evaluated to determine lidocaine bicarbonate solution
diffusion rates through the different membranous ETT cuffs. Estebe, et. al. (2014) and
Momato, et. al. (2015) both evaluated the integrity of the outer surface of each type of
ETT cuff showing no rupture while using polyurethane ETT cuff. Cuff rupture was
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noted, however, in the PVC ETT cuffs after six hours of intracuff lidocaine bicarbonate
solution. The outer membranous cuff surface became rough and was ruptured by manual
pressure applied by the fingers which occurred only in a few of the examined ETTs.
Research revealed that intracuff lidocaine was effective at decreasing the sedative
requirements for long-term mechanically ventilated patients and effective at decreasing
mucosal damage from ETT cuff inflation. The synthesis of evidence reveals that the use
of intracuff alkalinized lidocaine is a safe, effective route of administration to decrease
emergence cough to prevent hemodynamic alterations.
Theoretical Framework
The theoretical framework used with this DNP project is the Model for Change to
Evidence Based Practice. The model was developed by Rosswurm and Larrabee (1999)
as a model to guide healthcare professionals through a systematic approach for the need
to change to evidence-based practice. The increase in healthcare advances in clinical
research has led to shifts from traditional practice to evidence-based practice, allowing
advanced practice nurses to utilize the best research evidence in their patient care
treatment plan. The basis of this model from a theoretical approach is related to evidencebased practice, research utilization, and the change theory as described in Table 3.
(Rosswurm & Larrabee, 1999).
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Table 3
A Model for Change to Evidence Based Practice
A Model for Change to Evidence Based Practice
Step 1

Assess need for change by collecting and comparing data,
identifying practice problems.

Step 2

Link problems to interventions and outcomes using standardized
classification system and languages.

Step 3

Synthesize best evidence by searching research literature,
critiquing, rating and synthesizing best evidence, assessing
feasibility.

Step 4

Design practice changes by defining protocol change, planning a
pilot/demonstration including implementation, education,
resources needed.

Step 5

Implement and evaluate the practice change including evaluation
of pilot and decision to adapt/adopt/reject change

Step 6

Integrate and maintain change by communicating to
stakeholders, in-service education, approving practice standards
and monitoring outcomes.

Rosswurm and Larrabee (1999) proposed six unique steps involved in the model
framework which are: “1) Assess need for change in practice; 2) Link problem with
interventions and outcomes; 3) Synthesize best evidence; 4) Design a change in practice;
5) Implement and evaluate the change in practice; and 6) Integrate and maintain the
change in practice” (p. 319). The first step, assessing need for change in practice relates
to this DNP project through evaluating the need to keep patients hemodynamically stable
through all periods of anesthesia. Emerging patients from GETA can elicit a cough
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response that can cause brief hemodynamic alterations such as increased ICP, elevated
blood pressure, or tachycardia. Step two, linking problem with interventions and
outcomes could be considered through the use intracuff alkalinized lidocaine as an
intervention to decrease the problem of coughing during emergence. Intracuff alkalinized
lidocaine could lead to an overall outcome of no hemodynamic alterations experienced by
the patient. Step three, synthesizing the best evidence can be applied to this project
through the amount of evidence-based literature published over recent years concluding
intracuff alkalinized lidocaine to be an effective intervention at decreasing the cough
response. Step four implied a design to change practice done through this DNP project by
gathering evidence-based data and designing an evidence-based presentation to discuss a
practice change for CRNAs. Step five was achieved by proposing a practice change to
CRNAs suggesting the current evidence-based practice findings on the use of intracuff
alkalinized lidocaine. A practice change was determined by whether CRNAs changed
their practice or not. After the practice change proposal, a follow-up survey was
administered two weeks later to evaluate whether a practice change occurred by CRNAs.
Step six refers to integrating and maintaining the intervention for an improved practice
change. Integrating and maintaining the practice change can only occur if CRNAs were
willing to change practice based on evidence-based studies showing positive outcomes
with the use of intracuff alkalinized lidocaine. Each CRNA involved in this practice
change proposal could potentially play a large role in implementing this intervention into
long-term use. Based on outcomes and first-hand experiences by CRNAs this
intervention may become a sustainable treatment for decreasing emergence cough.
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The aim of this DNP project was to evaluate whether CRNAs were willing to
implement a practice change to decrease emergence cough and maintain hemodynamic
stability. The goal of implementing this evidence-based practice change proposal was to
determine if CRNAs were willing to change their current practice after being presented
with current evidence-based results on intracuff alkalinized lidocaine. By using the
framework established by Rosswurm and Larrabee (1999), a structured model to provide
a needed change in practice was implemented to reduce the cough response in patients
during emergence from general anesthesia.
Doctoral of Nursing Practice Essentials
This doctoral project met all eight DNP essentials as described in Appendix
A. Zaccagnini and White (2017) reported the use of these essentials in current practice
allowing advanced practice nurses (APNs) the skill set to enhance education. Essentials
III, VI, VIII were mostly reflected in this DNP project. Essential III, Clinical Scholarship
and Analytical Methods for Evidence-Based Practice, was reflected by using analytical
methods to appraise existing research on the effects of using intracuff alkalinized
lidocaine to reduce coughing during emergence. Essential III was also met by evaluating
quality improvement methods to collect, inform, and analyze current practice methods
through an evidence-based presentation on current research suggesting the use of
intracuff alkalinized lidocaine to practicing CRNAs. Essential VI, Interprofessional
Collaboration for Improving Patient and Population Health Outcomes, was reflected by
utilizing therapeutic communication and collaborative skills among anesthesia providers
to develop and implement a practice change in the health care system. Essential VIII,
Advanced Nursing Practice, was reflected by designing a practice change to improve
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patient safety and satisfaction. This project evaluated whether CRNAs were willing to
change practice based on reported evidence-based results of using intracuff alkalinized
2% lidocaine.
Summary
This project evaluated whether CRNAs were willing to change their practice
through utilizing intracuff alkalinized lidocaine to decrease emergence cough. This
project was presented through an evidence-based poster presentation and brochure to
CRNAs at a regional hospital in Southeastern Mississippi. All results were gathered via
paper survey administered prior to presentation and 2 weeks post-presentation. All
results will be evaluated by descriptive statistics to determine if CRNAs changed their
practice to utilize intracuff alkalinized lidocaine to decrease emergence cough.
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CHAPTER II - METHODOLOGY
The purpose of this DNP project was to evaluate the willingness of CRNAs to
change practice after presented evidence-based results from current research on benefits
of intracuff alkalinized lidocaine. It was estimated that 38% to 96% of patients receiving
GETA experienced coughing during emergence (As, Iqbal, & Ali, 2009). Synthesized
evidence revealed a correlation between using intracuff alkalinized lidocaine and
decreasing cough severity. Based on current research findings, an evidence-based
presentation was developed. For the GETA patient population, use of intracuff
alkalinized lidocaine is a proposed intervention that could be beneficial in decreasing
incidence or severity of coughing during emergence from anesthesia. The following
sections reveal the proposed method design, data collection, and data analysis that was
used to determine whether the practice change proposal was implemented by CRNAs.
Population
Inclusion criteria included all CRNAs employed at a level II trauma center in
southeast Mississippi. CRNAs at this facility administer anesthesia to patients of all
American Society of Anesthesiologists (ASA) physical status (PS) I - VI classifications
as described in Table 4. A total of 11,833 surgical cases were performed at this center in
2016 (U.S. News & World Report, 2017). This facility offers multiple surgical services
such as: Neurosurgery, cardiothoracic surgery, vascular surgery, orthopedic surgery, and
many other general surgery services. Exclusion criteria included any CRNA not willing
to participate in this DNP project or unable to attend the evidence-based presentation.
There was no random selection among the participating CRNAs.
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Table 4
American Society of Anesthesiologists Classification System
Physical Status

Class Definition

ASA PS 1

A normal healthy patient.

ASA PS 2

A patient with mild systemic disease.

ASA PS 3

A patient with severe systemic disease, not incapacitating.

ASA PS 4

A patient with severe systemic disease that is a constant threat to
life.

ASA PS 5

A moribound patient who is not expected to survive without the
operation.

ASA PS 6

A patient who has already been declared brain-dead and whose
organs are being removed for transplant.

E
Emergent surgery.
Note. ASA= American Society of Anesthesiologist. PS= Physical status.
Setting
A 512-bed level II trauma center in southeast Mississippi was the facility in which
this DNP project was presented to CRNAs. An evidence-based poster presentation and
brochure was presented in the anesthesia personnel lounge within the surgical department
at this facility. The anesthesia personnel lounge was a secure area, only accessible
through door code entry by authorized anesthesia personnel.
Design
The design was a practice change proposal offered to CRNAs through an
evidence-based poster presentation and brochure suggesting use of intracuff alkalinized
lidocaine to decrease emergence cough. CRNAs were presented with current research on
advantages of instilling alkalinized lidocaine into ETT cuffs to prevent emergence cough.
24

Prior to the presentation, each CRNA was asked to fill out a baseline paper survey
assessing their current knowledge on the use of intracuff alkalinized lidocaine. During
the evidence-based poster presentation and student nurse anesthetist (SRNA) developed
brochure was presented to each CRNA suggesting current dosages, onset, and peak effect
times of alkalinized lidocaine based on the synthesis of evidence current research
findings. Two weeks after presentation a secondary follow-up paper survey was
conducted to evaluate whether each CRNA implemented the practice change proposal or
to determine barriers which may have prevented them from implementing this
intervention. The feedback received from the follow-up survey allowed a determination
on whether CRNAs changed their current practice. There was no coding on the baseline
survey or follow-up survey. All results obtained from CRNAs on baseline survey or
follow-up survey remained anonymous.
No patient interaction occurred during implementation of this DNP project. Risk
of harm to any patient was avoided as this DNP project was solely a presentation of
evidence-based results on current research findings demonstrating the benefits of using
intracuff alkalinized lidocaine. No personal or confidential information was received on
any patient or participant during the project.
After successful Institutional Review Board (IRB) approval from The University
of Southern Mississippi (Protocol number: 17071703) and a letter of support from the
chief anesthesiologist at this facility, implementation of this DNP project was started. All
data received during this project implementation remained anonymous to ensure
participant confidentiality.

25

No identifiable personal information was collected from CRNAs on either survey.
All surveys were collected as aggregate data and not individualized to each CRNA.
Paper surveys were protected and maintained in a locked file cabinet for which the author
has the sole key. Six months after graduation requirements all computer data files will be
deleted and paper surveys shredded to ensure confidentiality of all participants involved
in this study.
Statistical Analysis
Statistical analysis was illustrated through descriptive statistics to describe the
population and whether a practice change was implemented by CRNAs. Descriptive
statistics are a form of statistical analysis used to quantitatively describe or summarize a
collection of information, usually a sample of data (Daniel, 2009). Descriptive statistics
were utilized for this DNP project to quantify the data from each survey completed.
After two weeks, an additional follow-up survey was handed out to CRNAs to gather
data on whether intracuff alkalinized lidocaine was implemented since the evidencebased presentation was presented. After gathering the follow-up survey results,
descriptive statistics were utilized and compared to original results to determine whether
implementation of this intervention had been effective. Measures of central tendency
such as the mean was calculated to determine average years of experience in which
CRNAs were willing to implement a practice change.
Summary
The population for this project included CRNAs at a 512-bed regional hospital in
Southeastern Mississippi. These CRNAs were currently not using intracuff alkalinized
lidocaine to prevent emergence cough. The CRNAs were presented with an evidence26

based poster presentation and brochure, which occurred in the anesthesia lounge. The
CRNAs completed baseline surveys prior to presentation and then completed follow-up
surveys two weeks after the presentation. Results were gathered on paper surveys and
maintained in a locked cabinet until data analysis. No personal or identifiable
information was gathered on CRNAs or patients. Descriptive statistics was utilized to
evaluate the survey results to determine if a practice change occurred among CRNAs.
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CHAPTER III - RESULTS
Statistical Analysis
A baseline survey was administered to 18 CRNAs of potentially 48 CRNAs at a
512-bed regional hospital in Southeastern Mississippi. The baseline survey was
administered prior to the delivery of each individual ten minute, evidence-based poster
presentation and brochure, which occurred in the anesthesia department lounge. After
completion of each individual presentation, the anesthesia provider was notified of a
follow-up survey to be completed after a two-week period elapsed. The paper follow-up
survey was hand-delivered to 12 CRNAs who participated in this DNP project. There
was no coding on follow-up surveys, CRNAs remained anonymous as aggregate data was
collected. The evidence-based presentation was presented during each CRNA’s normally
scheduled workday. Upon completion of the two-week period post-presentation, 12
follow-up surveys from the potential 18 CRNAs who participated in the baseline survey
were gathered and maintained in a locked file cabinet for which the author has the only
key.
Baseline Survey Results
Demographic data was initially gathered on all CRNAs participating in this
project to include years of experience, age, and gender. A total of 18 CRNAs received
the evidence-based presentation and participated in completing baseline surveys. Figure
1 illustrated years of experience among CRNAs showing 39% (n=7) had 1 to 5 years of
experience, 16% (n=3) had 6 to 10 years of experience, 39% (n=7) had 11 to 15 years of
experience, and 6% (n=1) had 21+ years of experience. The 18 CRNAs amassed 168
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years of anesthesia experience between them, ranging from 1 year to 35 years of
anesthesia experience, with mean of 9.3 years of experience (see Figure 1).
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N=18

Figure 1. Demographic Data: Years of Experience
Figure 2 depicts the age of the sample population of 18 CRNAs showing 11%
(n=2) between the ages of 21-30 years, 50% (n=9) between the ages of 31-40 years, 28%
(n=5) between the ages of 41-50 years, and 11% (n=2) who were 51+ years participated
in the baseline survey. The mean age of participants was 37 years old (see Figure 2).
Question 3 acquired the gender of the sample of 18 CRNAs, revealing 89% (n=16) males
and 11% (n=2) females. Of the potential 48 member CRNA population, males accounted
for 77% (n=37) compared to 23% (n=11) females (see Figure 3).
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Figure 2. Demographic Data: Age
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Figure 3. Demographic Data: Gender.
Questions 4-6 of the baseline survey inquired about the baseline usage,
knowledge of, and consideration for implementing the use of intracuff alkalinized
lidocaine among CRNAs in this project. Figure 4 illustrated current knowledge of using
intracuff alkalinized lidocaine to decrease emergence cough. The baseline survey
revealed 67% (n=12) of CRNAs were not familiar with the usage of intracuff alkalinized
lidocaine, while 33% (n=6) had previous knowledge of the intervention (see Figure 4).

Percentage of CRNAs

Knowledge of Intracuff Alkalinized
Lidocaine
80
60
40
20
0
Previous
Knowledge

No Previous
Knowledge

N=18

Figure 4. Knowledge of Intracuff Alkalinized Lidocaine
Figure 5 depicts previous intracuff alkalinized lidocaine knowledge among the 18
CRNAs. Of the 33% (n=6) of CRNAs familiar with the usage of intracuff alkalinized
lidocaine, only 11% CRNAs (n=2) had utilized the intervention in previous practice. The
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2 CRNAs reported utilizing 2% intracuff alkalinized lidocaine during their SRNA
training, administered during carotid endarterectomy surgery at another medical facility.
Most CRNAs, 67% (n=12) had no previous knowledge regarding using intracuff
alkalinized lidocaine to decrease emergence cough. CRNAs accounting for 22% (n=4) of
the sample reported knowledge of the intervention, but reported no use of intervention
because they were not required to implement the intervention (see Figure 5).
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Figure 5. Utilization of Intracuff Alkalinized Lidocaine
Figure 6 correlates with Question 6 of the baseline survey on whether the
proposed intervention would be considered in the CRNAs current practice, 78% (n=15)
reported they would consider the use of intracuff alkalinized lidocaine, while 22% (n=3)
answered maybe. No CRNA initially declined the consideration of using intracuff
alkalinized lidocaine. All 18 CRNAs asked to participate in the project voluntarily
agreed to participate in this project (see Figure 6).
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Figure 6. Consideration of Alkalinized Lidocaine Use
Two-week Data Collection, Follow-up Survey Results
Questions 1-3 of the follow-up survey acquired the demographics of the 12
CRNAs who participated in the project and who completed the follow-up survey and are
depicted in Figures 7-9. Figure 7 depicts years of anesthesia experience among CRNAs
showing 50% (n=6) had 1 to 5 years experience, 25% (n=3) had 6 to 10 years experience,
and 25% (n=3) had 11 to 15 years experience. The 12 CRNAs amassed 74 years of
experience between them, ranging from 1year to 15 years of experience, with mean of 6
years of experience (see Figure 7).
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Figure 7. Demographic Data: Years of Experience
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Figure 8 depicts the age of the sample population of 12 CRNAs, showing 25%
(n=3) CRNAs between the ages of 21-30 years, 50% (n=6) between the ages of 31-40
years, and 25% (n=3) between the ages of 41-50 years participated in the follow-up
survey. The median age was 36 years old (see Figure 8). Figure 9 depicts the gender of
the 12 CRNAs participating in the follow-up survey revealing 100% (n=12) of the
participants were male (see Figure 9).
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Figure 8. Demographic Data: Age
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Figure 9. Demographic Data: Gender.
Question 4 asked CRNAs if they implemented intracuff alkalinized lidocaine
since the evidence-based poster presentation and brochure were implemented. Of the 12
CRNAs, 33% (n=4) implemented intracuff alkalinized lidocaine, while 67% (n=8) of
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CRNAs did not implement the proposed intervention. Of the 4 CRNAs implementing the
intervention, 3 CRNAs had between 11-15 years of experience in anesthesia practice and
a mean age of 41 years old. The increased usage of intracuff alkalinized lidocaine from
0% to 33% among CRNAs participating in the project is demonstrated in Figure 10 (see
Figure 10).
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Figure 10. Intracuff Alkalinized Lidocaine Implementation
Figure 11 incorporated Question 5 and Question 6 acquiring how many cuff
inflations were implemented and how effective the intervention was at preventing
emergence cough. A total of 11 cuff inflations were implemented by 4 CRNAs in the
project. Of the 4 CRNAs, 2 CRNAs reported using 6 cuff inflations in total, preventing
emergence cough in all 6 patients who received the intervention. Another CRNA utilized
2 cuff inflations, reporting 1 episode of emergence cough due to case duration lasting less
than 2 hours. The last CRNA reported 3 cuff inflations in which 1 cuff inflation was
reported as not effective at preventing emergence cough. The CRNA reported the patient
was a chronic smoker and coughed immediately after extubation. The total of 11 cuff
inflations showed 82% (n=9) to be effective at preventing emergence cough, while 18%
(n=2) were deemed not effective at preventing emergence cough.
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Figure 11. Cuff Inflations Compared to Prevention of Emergence Cough
The final question of the follow-up survey asked CRNAs what barriers may have
prevented the use of intracuff alkalinized lidocaine. Figure 12 revealed the most common
barriers to using the intervention among CRNAs participating in this project. Of the 8
CRNAs (67%) who did not implement the intervention, 5 CRNAs (62%) reported no
recent patient interaction where the intervention would be beneficial. These 5 CRNAs
reported they would be willing to administer intracuff alkalinized lidocaine if they
believed it would be beneficial to the patient. Of the 3 CRNAs (38%) not willing to
implement the intervention, 1 CRNA (13%) reported there was not enough evidence to
support the intervention. The other 2 CRNAs (25%) reported not wanting to implement
this intervention due to the extra step of having to get sodium bicarbonate from pharmacy
and then having to take the time to prepare the medications (see Figure 12).
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Figure 12. Barriers to Implementing Intracuff Alkalinized Lidocaine
Summary
During the project, CRNAs at this facility increased the implementation of
intracuff alkalinized lidocaine from 0% to 33% to decrease or inhibit the emergence
cough reflex. Implementation of this intervention by CRNAs accomplished the primary
goal intended for this doctoral project. If barriers could be avoided, then CRNAs may
potentially further increase their utilization of intracuff alkalinized lidocaine. Further
discussion of the results, future implications, limitations, and dissemination of project are
provided within the next chapter.
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CHAPTER IV – DISCUSSION
Recommendations
The increased implementation of intracuff alkalinized lidocaine after evidencebased poster presentation and brochure demonstrated the project was successful during
the time frame of this project. Evaluation of the baseline survey data showed the major
barrier to using intracuff alkalinized lidocaine initially was the lack of knowledge about
the intervention among CRNAs. Follow-up surveys reflected that most CRNAs would
utilize the intervention if patients met the criteria for use. If the pharmacy premixed
lidocaine and sodium bicarbonate solution, perhaps there would be an even higher rate of
usage. Taking the time to mix these solutions as recommended could cause a short delay
in beginning anesthesia induction. This time constraint in the operating room could delay
workflow. Premixed solutions would allow the medications to be more readily available
and probably utilized more often in everyday anesthetic practice.
Implications for Future Practice
Comparable evidence-based educational presentations involving the results of
new studies on intracuff alkalinized lidocaine administration would be beneficial in
increasing usage of this intervention. Furthermore, presentations explaining other
benefits of intracuff alkalinized lidocaine such as decreasing severity of postoperative
sore throat (POST) for the initial 24 hours after extubation were demonstrated in
numerous evidence-based studies. This intervention could improve patient satisfaction
by decreasing severity of POST and decreasing the length of stay in the post-anesthesia
care unit (PACU). A study should also be conducted to evaluate the long-term outcomes
of patients who experienced emergence cough compared to patients in which emergence
37

cough reflex was inhibited from a hemodynamic standpoint. A future study focused on
hemodynamic stability during emergence could allow for evaluation of patient safety,
patient satisfaction, and quality of care. In my future career as a CRNA, I plan to utilize
the intervention of intracuff alkalinized lidocaine in patient s where the intervention
would be beneficial.
Limitations
The project was limited to CRNAs available and willing to participate in one
anesthesia department at a regional hospital in Southeastern Mississippi. A small sample
size of 18 CRNAs was obtained for this project. A larger sample size may have improved
the results of project. Implementing the evidence-based poster presentation and brochure
at numerous anesthesia departments could yield increased knowledge and usage of
suggested intervention among practicing CRNAs. A two-week time limit for
implementation of this project affected the results, as a longer duration of time for
implementation of this project may increase utilization among CRNAs.
Dissemination
Results of project will be disseminated to nursing research committee and
supervising anesthesiologist at hospital in which intervention was conducted. Project
dissemination will also be conveyed to Mississippi Association of Nurse Anesthetists
(MANA) and hopefully results of evidence-based study can be viewed by practicing
CRNAs all over the state of Mississippi. Project results will also be conveyed to junior
and freshmen student nurse anesthetists in hopes of one classmate continuing a further indepth project related to the benefits of intracuff alkalinized lidocaine.
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Conclusion
This project showed evidence that CRNAs who utilized this intervention saw
evidence of its effectiveness of inhibiting emergence cough reflex, thus avoiding
hemodynamic alterations. Though only a small percentage of the sample population
actually utilized the intervention, the positive results may allow for increased usage of
intracuff alkalinized lidocaine by these CRNAs. After the presentation, utilization of
intracuff alkalinized lidocaine among practicing CRNAs increased from 0% to 33%.
Future studies could be performed to assess how to avoid barriers that may reduce the
usage of intracuff alkalinized lidocaine such as premixing the lidocaine and bicarbonate
solution by the pharmacy. With the goal of reducing hemodynamic alterations caused by
emergence cough reflex, CRNAs can utilize this intervention to maintain patient
hemodynamic stability.
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APPENDIX A – DNP ESSENTIALS
Essential I: Scientific Underpinnings for
Practice

This doctoral research project described
advanced strategies to help decrease
emergence coughing that can elicit
detrimental complications.

Essential II: Organizational and Systems
Leadership for Quality Improvement and
Systems Thinking

This doctoral research project evaluated a
care delivery system through the use of
intra-cuff alkalinized lidocaine to improve
future needs and outcomes for patients
undergoing general anesthesia.

Essential III: Clinical Scholarship and
Analytical Methods for Evidence-Based
Practice

This doctoral research project used
analytical methods to appraise existing
research on the effects of using intra-cuff
lidocaine to reduce coughing during
emergence, designing and implementing a
strategy to evaluate the clinical outcomes of
current practice, furthermore evaluating
quality improvement methods to collect,
inform, and analyze current practice
methods.

Essential IV: Information
Systems/Technology and Patient Care
Technology for the Improvement and
Transformation of Health Care

This doctoral research project demonstrated
an effective ability to implement and
execute an evaluation plan for the use of
intra-cuff lidocaine by anesthesia
providers.

Essential V: Health Care Policy for
Advocacy in Health Care

This doctoral research project promoted
better outcomes for emerging patients from
general anesthesia by developing,
evaluating, and providing leadership to help
change health care policy for safer
anesthesia practice.

Essential VI: Interprofessional Collaboration This doctoral research project utilized
for Improving Patient and Population Health therapeutic communication and
Outcomes
collaborative skills among anesthesia
providers to develop and implement a
change in the health care system.
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Essential VII: Clinical Prevention and
Population Health for Improving the
Nation’s Health

This doctoral research project will
disseminate clinical findings to Mississippi
Association Nurse Anesthetist or American
Association Nurse Anesthetist upon
completion.

Essential VIII: Advanced Nursing Practice

This doctoral research project designed,
implemented, and evaluated an intervention
to improve emergence outcomes based on
nursing science and improving patient care.
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APPENDIX B – Hospital Research Request Approval Letter
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APPENDIX C – Letter of Support
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APPENDIX D – USM IRB Approval Letter
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Attention: By completing this survey you are consenting to this project and you are not
required to participate and may
withdrawEfrom
the study
at any time.
APPENDIX
– Baseline
Survey
Pre-Survey
Intracuff Alkalinized Lidocaine
1) Current years of anesthesia practice?
_____ years
2) Current Age?
_____ years
3) Gender?
o Male
o Female
4) Current knowledge on the use of intracuff alkalinized lidocaine to decrease emergence
cough?
o Familiar with the usage of intracuff alkalinized lidocaine.
o Not familiar with the usage of intracuff alkalinized lidocaine.
5) Have you ever utilized endotracheal tube cuff inflation with alkalinized lidocaine to
decrease emergence cough?
o Have used previously in anesthesia care.
o Have never used previously in anesthesia care.
6) Would you consider this proposed intervention in your current anesthesia practice?
o Yes
o No
o Maybe
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APPENDIX F – Follow-Up Survey
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APPENDIX G – Evidence-Based Poster
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